Validity of the timed 25-foot walk as an ambulatory performance outcome measure for multiple sclerosis.
about
The MSOAC approach to developing performance outcomes to measure and monitor multiple sclerosis disability.The Role of T1-Weighted Derived Measures of Neurodegeneration for Assessing Disability Progression in Multiple Sclerosis.Changes in disability in people with multiple sclerosis: a 10-year prospective study.Maximum walking speed in multiple sclerosis assessed with visual perceptive computing.Wearable biosensors to monitor disability in multiple sclerosis.Clinical outcome measures for progressive MS trials.Pulse Width Does Not Influence the Gains Achieved With Neuromuscular Electrical Stimulation in People With Multiple Sclerosis: Double-Blind, Randomized Trial.The measure tells the tale: Clinical outcome measures in multiple sclerosis.Movement measurements at home for multiple sclerosis: walking speed measured by a novel ambient measurement system.Test-retest agreement and reliability of the Six Spot Step Test in persons with multiple sclerosis.Effects of Rhythmic Auditory Cueing in Gait Rehabilitation for Multiple Sclerosis: A Mini Systematic Review and Meta-Analysis.Profiling walking dysfunction in multiple sclerosis: characterisation, classification and progression over time.Development of a gait module to complement the 12-item Multiple Sclerosis Walking Scale: a mixed methods studyMRI Markers and Functional Performance in Patients With CIS and MS: A Cross-Sectional Study
P2860
Q38629185-9EFC18D4-C60D-4609-806E-00380E08D7A2Q41475478-83C613A9-71B5-4A83-B7B2-0F8A433884E0Q47211254-3BCBBC0E-7B4E-4AA6-9D8F-947FB775512DQ47258006-10DDE79F-ECCF-43F2-AEBC-27ADFA8325EEQ47398671-78288D03-5268-4BC4-9CD6-7618DDDEE71FQ47892293-07850A3D-DF45-4213-946C-44B7834D405BQ48043976-4238DF5B-36FC-4569-8D24-C77A2534D87FQ48306207-43479D69-A62A-460E-A131-75C06C5A4149Q49172249-345B1CC4-72D3-4DA1-A79C-EE5AAEB79A2AQ50424266-8879C21D-54CD-4940-9743-C1EEEAF63197Q55248978-140C62F7-4613-48F7-AA29-E5787193884CQ55323826-34CCCF40-EA9B-4A2B-B265-1AF1233BF798Q56355709-7FF11B39-83EE-493E-A8BE-DFDE398DD882Q58694089-83431339-E737-4A75-A77A-31ADAD092611
P2860
Validity of the timed 25-foot walk as an ambulatory performance outcome measure for multiple sclerosis.
description
2017 nî lūn-bûn
@nan
2017 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2017 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
name
Validity of the timed 25-foot ...... easure for multiple sclerosis.
@ast
Validity of the timed 25-foot ...... easure for multiple sclerosis.
@en
type
label
Validity of the timed 25-foot ...... easure for multiple sclerosis.
@ast
Validity of the timed 25-foot ...... easure for multiple sclerosis.
@en
prefLabel
Validity of the timed 25-foot ...... easure for multiple sclerosis.
@ast
Validity of the timed 25-foot ...... easure for multiple sclerosis.
@en
P2093
P2860
P356
P1476
Validity of the timed 25-foot ...... easure for multiple sclerosis.
@en
P2093
Glenn Phillips
Jeffrey A Cohen
Lynn D Hudson
Multiple Sclerosis Outcome Assessments Consortium
Nicholas LaRocca
Ralph Benedict
Richard Rudick
Robert W Motl
P2860
P304
P356
10.1177/1352458517690823
P577
2017-02-01T00:00:00Z